 |
Covid-19 Fast Diagnostic Throat Test Kits , Nasal Swab Rapid Diagnostic Test Kit
Product Details:
| Place of Origin: | Beijing |
| Certification: | CE; ISO |
Payment & Shipping Terms:
| Minimum Order Quantity: | 10-100pcs |
|---|---|
| Price: | USD1.8-3.5/pc |
| Packaging Details: | 25pcs per case |
| Delivery Time: | 3-5working days |
| Supply Ability: | 1million per week |
|
Detail Information |
|||
| Sample Type: | Nasal/Throat Swab | Overall Agreement: | 97.5% |
|---|---|---|---|
| Certificate: | CE | Clinical Sensitivity: | 91.08% |
| Detection Substance: | Nucleic Acid | ||
| High Light: | Covid-19 Fast Diagnostic Throat Test Kits,Nasal Swab Rapid Diagnostic Test Kit |
||
Product Description
Covid-19 Fast Diagnostic Throat Test Kits , Nasal Swab Rapid Diagnostic Test Kit
CE approved Rapid Diagnostic Test Kit Antigen Fast Diagnostic Throat Test kits Nasal Swab Fast Test
Clinical Performance of Antigen Test for fresh swabs
Using 127 fresh NP swabs which were collected freshly in Extraction Buffer in the kit to evaluate the Clinical performance of the COVID-19 Antigen Rapid Test Kit. 67 Patients who presented within 7 days of symptom onset and 60 normal persons were included in the initial primary evaluation. The Result is below:
| Sansure Covid-19 RT-PCR Assay | ||||
| Positive | Negative | Total | ||
| Kewei COVID-19 Antigen Rapid Assay | Positive | 64 | 0 | 64 |
| Negative | 3 | 60 | 63 | |
| Total | 67 | 60 | 127 | |
The assay demonstrated acceptable clinical sensitivity for fresh swab samples is 95.52% (95% CI: 87.64%-98.47%) when compared to a molecular device produced by Sansure Inc. The assay demonstrated excellent clinical specificity 100% (95% CI: 93.98%-100%). Overall Agreement was 97.64% (93.28%-99.19%).
Want to Know more details about this product